<DOC>
	<DOCNO>NCT01563484</DOCNO>
	<brief_summary>Primary Hepatocellular Carcinoma ( PHC ) one common malignant tumor world . In men fifth frequently diagnose cancer worldwide second frequent cause cancer death . In woman , seventh commonly diagnose cancer sixth lead cause cancer death . An estimated 748,300 new liver cancer case 695,900 cancer death occur worldwide 2008 . Half case death estimate occur China . Surgical resection liver transplantation curative treatment option , le 20 % PHC patient candidate surgery . The prognosis patient unresectable PHC poor ; leave untreated , median survival le 6 month . Since transarterial chemoembolization ( TACE ) introduce palliative treatment patient unresectable HCC , become one common form interventional therapy . However , possibility treatment-related complication may offset survival benefit , especially worsen liver functions.TACE increase several parameter hepatic cytolysis decrease metabolic activity liver . Such deterioration liver function due ischemia follow TACE may result liver failure , even death . TACE also may adverse effect kidney . Radiographic contrast medium use obtain hepatogram TACE . It show use contrast medium increase risk renal failure , especially low-osmolar contrast medium . The aim trial compare change liver renal function TACE HCC iso-osmolar contrast medium low-osmolar contrast medium .</brief_summary>
	<brief_title>Comparison Liver Renal Function After Transarterial Chemoembolization Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media Low Osmolar Contrast Media</brief_title>
	<detailed_description>This prospective , randomize , single centre , single-blind study . Patients randomize ( 1:1 ) use Low-osmolar contrast medium iso-osmolar contrast medium TACE . On morning 2th 5th day TACE , hematologic check perform , hematologic check include serum creatinine , blood urea nitrogen , direct bilirubin , indirect bilirubin , alanine aminotransferase , aspartate aminotransferase , γ-glutamyltransferase , lactate dehydrogenase , alkaline phosphatase , cholinesterase . Then , compare data TACE .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1875 year ; PHC could treat surgery ; Patients clear consciousness，Cooperation ; Informed consent : authorization signature . Preexisting dialysis ; Known hypersensitivity contrast medium ; Complete portal vein thrombosis ( main trunk branch ) ; With severe cardiovascular renal disease ; Extensive arteriovenous shunting ; Insufficient function remain liver ( ChildPugh class C ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Primary Hepatocellular Carcinoma ( HCC )</keyword>
	<keyword>Transarterial chemoembolization ( TACE )</keyword>
	<keyword>Liver function</keyword>
	<keyword>Renal function</keyword>
</DOC>